Services 

biopharma servicesOur mission is to help translate discoveries from academic and biopharma research labs by bringing analytical rigour and clinical expertise to the qualification, validation and testing of blood based protein biomarkers. 

  • Routine and esoteric biomarker analysis - any study size catered for from small discovery cohorts through to large longitudinal studies including public health projects
  • Extensive experience with a range of matrices including serum, saliva, faeces, plasma, urine and CSF
  • Single analyte and multiplex assay validation and testing
  • Range of platforms including ELISA, clinical chemistry, immunoassay, haematology and multiplex systems including MSD
  • Assay validation including preanalytical factors assessment such as sample collection, sample and analyte stability testing
  • Method optimisation and validation for assays ‘tech transferred’ to Affinity Biomarker Labs
  • Support for diagnostic and companion assay development including platform validation & clinical sample analysis

Mass Spectrometry Services NEW!

Small Molecules Analysis

Biochemical Analysis

  • Amino acids
  • Organic acids
  • Amines
  • Fatty Acids
  • VOC’s
  • Targeted Metabolomics
  • Untargeted Metabolomics

 Therapeutic Drug Analysis

  • Drug adherence
  • Pharmacokinetics
  • Drug metabolism

Protein Analysis

Bottom up protein analysis

  • Protein identification
  • Shot-gun proteomics
  • Protein quantitation
  • Proteomics

 Top down protein analysis

  • Protein identification
  • Isoform analysis

  Post translational modifications

  •  Glycosylation
  • Phosphorylation

Analytical Consultancy and Diagnostic Development Services

 

 

 

 

Academia

Academia

With an extensive track record working with academic groups Affinity Biomarker Labs is ideally positioned to support academic research groups.

FIND OUT MORE

Biopharma

Biopharma

The use of biomarkers has the potential to facilitate the availability of safer and more effective drug or biotechnology products, to guide dose selection, and to enhance their benefit-risk profile.

FIND OUT MORE

Clinical

Clinical

The practice of medicine has long been shifting from the classical model of clinical care to the application of biomarker guided decision making.

FIND OUT MORE